Sentence examples for mg demonstrated a from inspiring English sources

10 12 The use of topiramate, a kind of AED, at a daily dose of 50 mg demonstrated a favourable effect in reducing the migraine days.

Clopidogrel loading 300 mg or 600 mg demonstrated a 40% increase in mean dabigatran drug plasma concentration and a 30% increase in mean dabigatran AUC.

Parameters such as employment and a stable course of MG demonstrated a positive influence on physical health (explanation of variance = 60.9% (adjusted R2 = 0.609)).

A 6-week, placebo-controlled study with benfotiamine 300 mg or 600 mg demonstrated a reduction in neuropathic symptoms, which was optimal at the higher dose.

After 31 months of follow-up (Buzdar et al, 1998), anastrozole (1 mg) demonstrated a significant survival advantage over megestrol acetate (Table 1).

Figure  2 shows that the IVR 0.5 mg demonstrated a higher proportion of patients who gained ≥15 ETDRS letters, compared to non-anti-VEGF (RR, 2.36; 95% CI: 1.86, 2.99; P < 0.001) at the follow-up endpoint.

Moreover, the Δ PaGlo1 strain is unable to grow at all on PASM 1% glucose + 40 μM MG demonstrating an essential role of PaGLO1 to detoxify MG.

Conclusions: violent schizophrenia patients treated with fish oil (360 mg DHA + 540 mg EPA) demonstrated a decrease in violence, but improvement in positive and negative symptoms was no greater than patients treated with the placebo after twelve weeks.

At 52 weeks, canagliflozin 300 mg demonstrated noninferiority and, in a subsequent assessment, showed superiority to sitagliptin 100 mg in reducing A1C (−1.03% [−11.3 mmol/mol] and −0.66% [−7.2 mmol/mol], respectively; least squares mean difference between groups, −0.37% [95% CI, −0.50 to −0.25] or −4.0 mmol/mol [−5.5 to −2.7]).

Both lumiracoxib 100 mg od and celecoxib 200 mg od demonstrated a statistically significant improvement in OA symptoms compared with placebo when analysing conventional outcome variables (OA pain, patient's global assessment of disease activity, and the WOMAC™ questionnaire total score) [ 6, 7].

Subjects with familial adenomatous polyposis (FAP) who received celecoxib for six months at 400 mg bid, but not those receiving 100 mg bid, demonstrated a significant reduction, compared to placebo, in mean polyp number [ 12].